These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1254 related items for PubMed ID: 27373356

  • 1. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ, Wei H, Duan LP, Zhu SW, Zhang L, Wang K.
    Zhonghua Yi Xue Za Zhi; 2016 Jun 28; 96(24):1896-902. PubMed ID: 27373356
    [Abstract] [Full Text] [Related]

  • 2. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.
    Zhao J, Zheng X, Chu H, Zhao J, Cong Y, Fried M, Fox M, Dai N.
    Neurogastroenterol Motil; 2014 Jun 28; 26(6):794-802. PubMed ID: 24641100
    [Abstract] [Full Text] [Related]

  • 3. [The dietary features of diarrhea predominant irritable bowel syndrome patients with small intestinal bowel overgrowth].
    Wei H, Liu ZJ, Wang K, Zheng W, Duan LP.
    Zhonghua Nei Ke Za Zhi; 2017 Aug 01; 56(8):567-571. PubMed ID: 28789488
    [Abstract] [Full Text] [Related]

  • 4. Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain.
    Collins BS, Lin HC.
    J Pediatr Gastroenterol Nutr; 2011 Apr 01; 52(4):382-6. PubMed ID: 21240023
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Determination of rifaximin treatment period according to lactulose breath test values in nonconstipated irritable bowel syndrome subjects.
    Bae S, Lee KJ, Kim YS, Kim KN.
    J Korean Med Sci; 2015 Jun 01; 30(6):757-62. PubMed ID: 26028929
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.
    Tuteja AK, Talley NJ, Stoddard GJ, Verne GN.
    Dig Dis Sci; 2019 Mar 01; 64(3):838-845. PubMed ID: 30370492
    [Abstract] [Full Text] [Related]

  • 10. Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome.
    Ning Y, Lou C, Huang Z, Chen D, Huang H, Chen L, Zhang B, Dai N, Zhao J, Zhen X.
    Hell J Nucl Med; 2016 Mar 01; 19(2):124-9. PubMed ID: 27331205
    [Abstract] [Full Text] [Related]

  • 11. Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.
    Weinstock LB, Geng B, Brandes SB.
    Can J Urol; 2011 Aug 01; 18(4):5826-30. PubMed ID: 21854715
    [Abstract] [Full Text] [Related]

  • 12. Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial.
    Majewski M, McCallum RW.
    Adv Med Sci; 2007 Aug 01; 52():139-42. PubMed ID: 18217406
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study.
    Scarpellini E, Giorgio V, Gabrielli M, Lauritano EC, Pantanella A, Fundarò C, Gasbarrini A.
    J Pediatr; 2009 Sep 01; 155(3):416-20. PubMed ID: 19535093
    [Abstract] [Full Text] [Related]

  • 14. The relationship between small intestinal bacterial overgrowth and irritable bowel syndrome.
    Ding XW, Liu YX, Fang XC, Liu K, Wei YY, Shan MH.
    Eur Rev Med Pharmacol Sci; 2017 Nov 01; 21(22):5191-5196. PubMed ID: 29228433
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.
    Moraru IG, Moraru AG, Andrei M, Iordache T, Drug V, Diculescu M, Portincasa P, Dumitrascu DL.
    Rom J Intern Med; 2014 Nov 01; 52(3):143-50. PubMed ID: 25509557
    [Abstract] [Full Text] [Related]

  • 18. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.
    Ghoshal UC, Srivastava D, Ghoshal U, Misra A.
    Eur J Gastroenterol Hepatol; 2014 Jul 01; 26(7):753-60. PubMed ID: 24849768
    [Abstract] [Full Text] [Related]

  • 19. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance.
    Wu KQ, Sun WJ, Li N, Chen YQ, Wei YL, Chen DF.
    Scand J Gastroenterol; 2019 Dec 01; 54(12):1419-1425. PubMed ID: 31765575
    [Abstract] [Full Text] [Related]

  • 20. Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome.
    Boltin D, Perets TT, Shporn E, Aizic S, Levy S, Niv Y, Dickman R.
    Ann Clin Microbiol Antimicrob; 2014 Oct 17; 13():49. PubMed ID: 25319626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.